<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0005226.ref045">
 <label>45</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Kortekaas</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Zingeser</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>de Leeuw</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>de La Rocque</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Unger</surname>
   <given-names>H</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2011</year>) 
  <article-title>Rift Valley Fever vaccine development: progress and constraints</article-title>. 
  <source>Emerg Infect Dis</source>. 
  <volume>17</volume>: 
  <fpage>e1</fpage>.
 </mixed-citation>
</ref>
